Highlights From ACC.22 – Consultant 360

… and APOLLO Trials, 3-year follow-up data from the SPYRAL HTN-ON MED Study, and studies on coffee consumption and cardiovascular risk. Videos.Read More

Share this article:
Previous Post: Luckin Coffee is Back with a Vengeance – and Perhaps More Than Just That | EqualOcean

May 4, 2022 - In Coffee Industry

Next Post: Starbucks misses sales estimates on China COVID curbs, suspends guidance – BusinessToday

May 4, 2022 - In Coffee Consumption, Coffee Industry

Related Posts

Leave a Reply

Your email address will not be published.